US PTA prices were unchanged at FOB Charleston in October 2025, despite DAK Americas closing its Cape Fear plant (550,000 t/y) with no plans to reopen on account of economic stresses. Supply tightness was offset by plunging PX/crude charges – Brent went down to USD 63/bbl on US inventory build, Saudi hikes, and seasonal demand dip, softening production by USD 35-40/MT. The Demand for PTA remained sluggish: polyester units operated at 70-75%, weaving at less than 56%, textile at sample order, and finished goods stocks were high (18-20 days). There was no export interest on account of Chinese oversupply and US vPET/rPET tariffs. Port delays (Savannah 4-6 days, Houston curbs) also created friction, but freight dropped, offsetting the effect. As per ChemAnalyst, the November outlook for the PTA market could be rangebound by holiday restock.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
